D89.831

Clinical Causes: Immunotherapy treatments such as CAR T-cell therapy or monoclonal antibodies Certain infections or viral illnesses can sometimes trigger CRS Other immune-modulating therapies used in cancer treatment

Key Symptoms: Mild fever Fatigue or weakness Muscle or joint pain Mild rash Low blood pressure (hypotension) Elevated heart rate (tachycardia) Mild shortness of breath Swelling or edema in some cases Digestive symptoms like nausea

Diagnosis Path: Diagnosis of grade 1 cytokine release syndrome involves a combination of clinical assessment and laboratory tests. Healthcare providers observe the patient's symptoms and vital signs, especially noting fever, blood pressure, and heart rate. Blood tests may show elevated inflammatory markers such as C-reactive protein (CRP) or ferritin, and other labs can help rule out infections or other causes. The grading of CRS—here, grade 1—reflects the severity of symptoms and guides treatment strategies. Regular monitoring during and after immunotherapy is crucial for early detection.

Treatment Protocols: Management of grade 1 CRS typically involves supportive care aimed at relieving symptoms and preventing progression. This may include: - Rest and hydration to help reduce symptoms - Over-the-counter medications such as acetaminophen to control fever - Close monitoring of vital signs - Adjustments to immunotherapy treatments if necessary - In some cases, corticosteroids or cytokine inhibitors like tocilizumab may be considered if symptoms worsen or persist Most patients with grade 1 CRS recover fully with appropriate management, and it rarely requires intensive interventions. Ongoing communication with healthcare providers is essential for effective management and to monitor for any escalation in severity.